Lista de obras -

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack

artículo científico publicado en 2016

Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity

scientific article published on 01 March 2019

Adherence reporting in randomized controlled trials

artículo científico

Altruism as a reason for participation in clinical trials was independently associated with adherence

artículo científico publicado en 2005

An Error in An Old Paper Illustrates the Need for Data/Code Archives - Author response

scientific article published on 20 November 2018

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

artículo científico

Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measure

artículo científico publicado en 2002

Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke Trial

artículo científico publicado en 2005

Diabetes prevention and cardiovascular complications

scientific article published on 14 September 2019

Disagreement between students and preceptors regarding the value of teaching behaviors for ambulatory care settings

artículo científico publicado en 2008

Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial.

artículo científico publicado en 2018

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

artículo científico publicado en 2017

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

artículo científico publicado en 2005

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

artículo científico publicado en 2018

Influence of race, clinical, and other socio-demographic features on trial participation

artículo científico publicado en 2003

Litigation seeking access to data from ongoing clinical trials: a threat to clinical research

artículo científico publicado en 2014

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable

artículo científico publicado en 2003

Major risk factors for intracerebral hemorrhage in the young are modifiable

artículo científico publicado en 2005

Metabolic rehabilitation: science gathers to support a new intervention to prevent stroke

artículo científico publicado en 2011

Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease

artículo científico publicado en 2018

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

artículo científico publicado en 2016

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

artículo científico publicado en 2017

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

artículo científico publicado en 2019

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

artículo científico publicado en 2016

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

artículo científico publicado en 2016

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

artículo científico publicado en 2014

Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke

artículo científico publicado en 2003

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

artículo científico publicado en 2005

Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

artículo científico publicado en 2017

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

scientific article published on 10 December 2018

Smoking cessation and outcome after ischemic stroke or TIA.

artículo científico publicado en 2017

Taking care of volunteers in a stroke trial: a new assisted-management strategy

artículo científico publicado en 2016

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

artículo científico publicado en 2017

Lista de obras de

A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack

Achievement of Guideline-Recommended Weight Loss Among Patients With Ischemic Stroke and Obesity

Adherence reporting in randomized controlled trials

Altruism as a reason for participation in clinical trials was independently associated with adherence

An Error in An Old Paper Illustrates the Need for Data/Code Archives - Author response

Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus

Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measure

Decline in physical performance among women with a recent transient ischemic attack or ischemic stroke: opportunities for functional preservation a report of the Women's Estrogen Stroke Trial

Diabetes prevention and cardiovascular complications

Disagreement between students and preceptors regarding the value of teaching behaviors for ambulatory care settings

Distance from Home to Research Center: A Barrier to In-Person Visits but Not Treatment Adherence in a Stroke Trial.

Effects of pioglitazone on cognitive function in patients with a recent ischaemic stroke or TIA: a report from the IRIS trial

Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST).

Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone

Influence of race, clinical, and other socio-demographic features on trial participation

Litigation seeking access to data from ongoing clinical trials: a threat to clinical research

Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable

Major risk factors for intracerebral hemorrhage in the young are modifiable

Metabolic rehabilitation: science gathers to support a new intervention to prevent stroke

Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease

Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial

Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial

Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke

Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke

Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk

Smoking cessation and outcome after ischemic stroke or TIA.

Taking care of volunteers in a stroke trial: a new assisted-management strategy

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.